⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Michael SilberMBCHB

Neurology · Rochester, MN 55905

NPI: 1194705525

Share:

36

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

195

Total Claims

$107K

Drug Cost

49

Beneficiaries

$2,186

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+3

Score components are additive. Read full methodology

Peer Comparison vs. 13,194 Neurology providers

+3155%

Opioid rate vs peers

42.6% vs 1.3% avg

-46%

Cost per patient vs peers

$2,186 vs $4,034 avg

+102%

Brand preference vs peers

19.0% vs 9.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 3,155% above the average for Neurology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

42.6%

Opioid Rate

83

Opioid Claims

$6,286

Opioid Cost

59.0%

Long-Acting Rate

This provider's opioid prescribing rate of 42.6% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

81% generic

Brand: 37 claims · $99K

Generic: 158 claims · $8,474

Patient Profile

69

Avg Age

53%

Female

0.92

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About